Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$2.64B
+57.1% from 2023
Prescriptions
198K
$13,334.05 per claim
Patients
30K
10,560 prescribers
Total spending, 2024
$2.64B
$87,001.87 per patient
Medicare prescription drug plans paid $2.64B for Lenalidomide in 2024, for 197,995 prescriptions and refills to 30,339 patients (up 57.1% from 2023). The average cost per claim was $13,334.05.
California had the highest Medicare cost for Lenalidomide in 2024: $318.9M for 25,305 claims, followed by New York ($226.8M).
Emerentia A Agyemang, nurse practitioner in Boston, MA, had the highest Medicare cost for Lenalidomide in 2024: 537 claims costing $6.5M.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Emerentia A Agyemang Boston, MA | Nurse Practitioner | 537 | 85 | $6.5M |
| Jennifer E Miller Rochester, NY | Nurse Practitioner | 366 | 77 | $5.7M |
| Gina B Fries |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 5,315 | 32,301 | 9,847 | $448.2M |
| 2023 | 8,741 | 121,722 | 20,385 | $1.68B |
| 2024 | 10,560 | 197,995 | 30,339 | $2.64B |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Physician Assistant |
| 361 |
| 73 |
| $5.2M |
| Ami P Ndiaye Charlotte, NC | Nurse Practitioner | 355 | 88 | $5.0M |
| Rachid C Baz Tampa, FL | Hematology-Oncology | 340 | 71 | $4.8M |
| Ian T Lund Buffalo, NY | Physician Assistant | 285 | 94 | $4.7M |
| Andrew P Dalovisio Baton Rouge, LA | Hematology-Oncology | 314 | 60 | $4.6M |
| Katie Jones New York, NY | Nurse Practitioner | 312 | 80 | $4.5M |
| Larry D Anderson Jr. Dallas, TX | Hematopoietic Cell Transplantation and Cellular Therapy | 360 | 49 | $4.4M |
| Ferdinand D Dayalo South El Monte, CA | Nurse Practitioner | 366 | 51 | $4.4M |
| Michael M Green Baltimore, MD | Hematology-Oncology | 359 | 46 | $4.3M |
| Sascha A Tuchman Durham, NC | Hematopoietic Cell Transplantation and Cellular Therapy | 279 | 39 | $4.2M |
| Kristina M Slemmer Buffalo, NY | Physician Assistant | 251 | 88 | $4.2M |
| Jordan D Robinson Charlotte, NC | Physician Assistant | 291 | 80 | $4.1M |
| Kenneth S Poon San Leandro, CA | Hematology-Oncology | 341 | 35 | $3.7M |
| Kevin Brigle Richmond, VA | Nurse Practitioner | 261 | 37 | $3.5M |
| Hailey Battaglia Knight Chicago, IL | Physician Assistant | 217 | 93 | $3.5M |
| Jill N Burke Boston, MA | Nurse Practitioner | 252 | 32 | $3.4M |
| Brandon J Blue Tampa, FL | Hematology-Oncology | 240 | 50 | $3.4M |
| Craig C Hofmeister Atlanta, GA | Hematology | 240 | 38 | $3.3M |
| Susan Y Kao Berkeley, CA | Internal Medicine | 245 | 28 | $3.2M |
| Sendhilnathan Ramalingam Durham, NC | Hematology-Oncology | 244 | 39 | $3.2M |
| Al-Ola A Abdallah Tulsa, OK | Hematology | 234 | 50 | $3.2M |
| Nisha S Joseph Atlanta, GA | Medical Oncology | 223 | 29 | $3.1M |
| Michael Toole Fort Wayne, IN | Hematology-Oncology | 211 | 32 | $3.1M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Teva Pharm TEVA | 66,919 | $876.3M |
| Dr.Reddy'S Lab RDY | 37,825 | $503.6M |
| Alvogen Inc | 25,519 | $354.5M |
| Apotex Corp | 21,196 | $289.9M |
| Cipla USA, Inc. CIPLA.NS | 9,628 | $129.5M |
| Zydus Pharmaceu ZYDUSLIFE.NS | 8,247 | $115.3M |
| Sun Pharmaceuti SUNPHARMA.NS | 8,414 | $108.8M |
| Mylan VTRS | 9,027 | $107.1M |
| Camber Pharmace | 6,536 | $90.8M |
| Aurobindo Pharm AUROPHARMA.NS | 4,756 | $64.9M |